CRSP
CRISPR Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.40 / 10
Outperform
Technically, CRSP scores 6.4/10 with constructive signals from Long Upper Shadow and MACD Golden/Death Crosses, offset by a Bearish Engulfing pattern. The trend is cautiously optimistic, suggesting potential upside if bullish momentum persists.
Analysis Checks(3/4)
Long Upper Shadow
Score7.9/10
Win Rate65.62%
Hist. Signals32
Avg Return1.12%
Score7.9/10
Win Rate65.62%
Hist. Signals32
Avg Return1.12%
MACD Death Cross
Score6.65/10
Win Rate58.33%
Hist. Signals12
Avg Return3.75%
Score6.65/10
Win Rate58.33%
Hist. Signals12
Avg Return3.75%
Bearish Engulfing
Score4.23/10
Win Rate50.00%
Hist. Signals6
Avg Return0.85%
Score4.23/10
Win Rate50.00%
Hist. Signals6
Avg Return0.85%
MACD Golden Cross
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return2.59%
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return2.59%
Long Upper Shadow
Score7.9/10
Win Rate65.62%
Hist. Signals32
Avg Return1.12%
Score7.9/10
Win Rate65.62%
Hist. Signals32
Avg Return1.12%
Bearish Engulfing
Score4.23/10
Win Rate50.00%
Hist. Signals6
Avg Return0.85%
Score4.23/10
Win Rate50.00%
Hist. Signals6
Avg Return0.85%
MACD Death Cross
Score6.65/10
Win Rate58.33%
Hist. Signals12
Avg Return3.75%
Score6.65/10
Win Rate58.33%
Hist. Signals12
Avg Return3.75%
MACD Golden Cross
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return2.59%
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return2.59%
What is the current technical signals for CRSP?
- CRSP presents a Outperform setup with a Technical Score of 6.40/10. Key technical indicators highlight an RSI of 41.00 and a MACD of -1.44, with the trend anchored by the 50-Day SMA at 54.69. Traders should monitor key support at 44.40 and resistance at 48.50.
